Trial Profile
Effect of addition of ivabradine to beta-blockers during cardiac rehabilitation in patients with recent coronary artery bypass
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Bisoprolol
- Indications Coronary artery disease
- Focus Therapeutic Use
- 14 May 2014 New trial record
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.